RxDoctor Payments Data

Dominic Koh

Pediatrics · Los Angeles, CANPI 1487657029

Payments from drug & device makers

$595in general payments, 2019–2025

Across 26 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$143
  • Novo Nordisk$126
  • GSK$97
  • Bayer$56
  • Sanofi Pasteur Inc.$36
  • Pfizer$28
  • plus $109 from 5 others

What the payments were for

  • Food & beverage$595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$595 in reported general payments places this provider in the 75th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California

Medicare billing

Part B allowed, 2024
$639
Medicare patients
43
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Synjardy XrEmpagliflozin/Metformin Hcl141$186,334
RybelsusSemaglutide73$161,208
TrulicityDulaglutide62$94,610
OzempicSemaglutide78$87,937
MounjaroTirzepatide60$70,143
SynjardyEmpagliflozin/Metformin Hcl54$68,762
JardianceEmpagliflozin36$55,431
EliquisApixaban15$25,049
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog52$21,227
InvokametCanagliflozin/Metformin Hcl11$17,719
FarxigaDapagliflozin Propanediol14$13,196
Atorvastatin Calcium708$6,515
Repatha SureclickEvolocumab12$6,459
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide105$4,249
Rosuvastatin Calcium125$3,498

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$126$249,144151 claims
Lilly USA, LLCTrulicity, Mounjaro$143$164,752122 claims
PfizerEliquis$28$25,04915 claims
GSKArnuity Ellipta$97$2,23911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 5,539 pediatrics providers in California.

Other pediatrics in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →